halicin

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namehalicin
Drug Alias Namerepurposed SU-3327 (Massachusetts Institute of Technology)SU-3327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsCarbapenem-Resistant InfectionStaphylococcal Infections +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts Institute Of Technology
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii InfectionsCarbapenem-Resistant InfectionStaphylococcal Infections +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A